The needle-free injection system market growth driven by the increasing incidence of communicable diseases due to needlestick injuries and rising demand for self-injection devices. The fillable needle-free injectors segment held the largest share of the market in the global needle free injection system market contributing a market share of 63.6% in 2021.
New York, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Needle-Free Injection System Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Fillable Needle free Injectors and Prefilled Needle free Injectors), Technology (Jet-Based Needle free Injectors, Spring-Based Needle free Injectors, Microarray Patch Injectors, and Others), Type (Liquid-Based Needle free Injectors, Projectile-based Needle free Injectors, and Powder-Based Needle free Injectors), Usability (Disposable and Reusable), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Dermatology, and Others), and End User (Hospitals, Home Care Settings, Research Laboratories, Pharmaceutical & Biotechnological Companies, and Other End User)”, the global needle-free injection system market size is expected to grow from USD 131.64 million in 2021 to USD 411.31 million by 2028; it is estimated to grow at a CAGR of 17.7% from 2022 to 2028.
Download Sample Brochure of Needle-Free Injection System Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.theinsightpartners.com/sample/TIPRE00009273/
Needle-Free Injection System Market Report Scope & Strategic Insights:
No. of Charts & Figures
Product, Technology, Type, Usability, Site of Delivery, Application, and End User
North America; Europe; Asia Pacific; Latin America; MEA
US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Needle Free Injection System Market: Competitive Landscape and Key Developments The global needle free injection system market includes key players such as Crossject; INOVIO Pharmaceuticals; Zealand Pharma A/S; PharmaJet; Portal Instruments; Medical International Technologies (MIT Canada) Inc.; NuGen Medical Devices; Ferring B.V.; National Medical Products, Inc.; and Aijex Pharma International Inc. These players are focusing on expanding, diversifying their market presence, and acquiring a novel customer base, thereby tapping prevailing business opportunities.
Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00009273/
In June 2022, NuGen Medical Devices Inc., a leader in needle free drug delivery, announced that the company will launch a needle free injection device specifically designed for domesticated household pets. The PetJet will allow pet owners and veterinarians to safely and quickly inject various types of medication without the fear of hurting their pets with a traditional hypodermic needle.
In October 2020, PharmaJet, the maker of innovative, needle free injection technology, announced that its Stratis Needle-free Injection System was used to deliver a vaccine against SARS-CoV-2 in a clinical trial in Australia. The PharmaJet System was chosen due to its record of increasing the efficacy of DNA vaccines and speed of the delivery system compared to traditional needles and syringes.
Liquid-Based Needle Free Injectors Segment to Lead Needle-Free Injection System Market During 2022–2028: The report highlights the key factors driving the market and prominent players with their developments. The growth of the needle free injection system market is primarily attributed to the increasing incidence of communicable diseases due to needlestick injuries (NSIs) and the advantages of using self-injection devices. However, higher development costs of needle free injectors compared to conventional injection systems are hindering the growth of the market.
In 2021, North America dominated the needle free injection system market. The US is one of the major countries mainly attributed to the rise in the development of noninvasive needle free injection system devices and the exponential rise in the infectious diseases caused due to NSIs. For instance, according to the Occupational Safety and Health Administration (OSHA), in 2020, ~5.6 million healthcare personnel in the US were at risk of work-related exposure to blood-borne pathogens via needlestick or other sharps-related injuries. Further, 44% of all NSIs are caused in operating rooms, followed by 26% in patient rooms and 8% in emergency rooms and outpatient clinics, respectively.
Speak to Research Expert: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00009273
Further, market players are adopting organic and inorganic strategies for market development, such as advanced product launches. For instance, in June 2022, NuGen Medical Devices Inc. announced the launch of a new online brand store for its InsuJet needle free injection device. The brand store is now live to make InsuJet available for purchase in the European Union (EU).
Rising Demand for Vaccines and Biosimilars: The use of biosimilars is increasing in the treatment of various ailments such as cancer, hepatitis, diabetes, and several other acute and chronic diseases. With the rising prevalence of these illnesses, the need for biosimilars is also increasing, which is presenting a huge opportunity for pharmaceutical & MedTech manufacturers to develop innovative delivery solutions for biosimilars. As several biosimilars and vaccines are administered through injections, the use of needle free injection technology can provide an easy-to-use and safe method for administering biosimilars without a traditional injection apparatus or skilled staff. Further, many biopharmaceutical manufacturers, vaccine companies, and needle free device manufacturers are entering into strategic acquisitions and collaborations to leverage the growth potential in the vaccine market. Therefore, the launch of effective and safe drug delivery devices using needle free injection technology is expected to boost the market growth in the coming years. For instance, in January 2019, Enesi Pharma and Geovax collaborated on multiple vaccines administered using Implavax needle free injection devices. Furthermore, in August 2021, PharmaJet partnered with Zydus Cadila for the world’s first plasmid DNA COVID-19 vaccine delivery via needle free injection. In addition, the company partnered with Abnova to produce and supply the COVID-19 mRNA vaccine using needle free injection technology. Thus, all these factors encouraging the ease-to-use benefit of these injectors will provide more opportunities for the companies to develop innovative products, which is expected to boost the growth of the needle free injection system market. Many patients have a phobia for needles, which has led to the low demand for injectable devices; as a result, many companies are now aiming to develop needle free injectors with effective and painless solutions.
Get Discount on “Needle-Free Injection System Market” Research Study: https://www.theinsightpartners.com/discount/TIPRE00009273/
Needle Free Injection System Market: Segmental Overview Based on product, the global needle free injection system market is bifurcated into fillable needle free injectors and prefilled needle free injectors. In 2021, the fillable needle free injectors segment accounted for a larger market share. However, the prefilled needle free injectors segment is anticipated to register a higher CAGR from 2022 to 2028.
Based on technology, the global needle free injection system market is segmented into jet-based needle free injectors, spring-based needle free injectors, microarray patch injectors, and others. The jet-based needle free injectors segment held the largest market share in 2021 and is expected to register the highest CAGR during the forecast period.
Based on type, the global needle free injection system market is segmented into liquid-based needle free injectors, projectile-based needle free injectors, and powder-based needle free injectors. The liquid-based needle free injectors segment held the largest market share in 2021. However, the projectile-based needle free injectors segment is expected to register the highest CAGR during the forecast period.
Based on usability, the global needle free injection system market is bifurcated into disposable and reusable. The reusable segment held a larger market share in 2021. However, the disposable segment is expected to grow with a higher CAGR during the forecast period.
Based on site of delivery, the global needle free injection system market is segmented into subcutaneous injectors, intramuscular injectors, and intradermal injectors. The subcutaneous injectors segment held the largest market share in 2021, and it is expected to register the highest CAGR during the forecast period.
Buy Premium Copy of Needle-Free Injection System Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00009273/
Based on application, the global needle free injection system market is segmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and others. The vaccine delivery segment held the largest market share in 2021, and it is expected to register the highest CAGR during the forecast period.
Based on end user, the global needle free injection system market is segmented into hospitals, home care settings, research laboratories, pharmaceutical and biotechnology companies, and other end users. The hospitals segment held the largest market share in 2021, and it is expected to register the highest CAGR from 2022 to 2028.
Browse Adjoining Reports: Intradermal injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method (Normal Sized Needles, Short Needle {Intradermal Microinjection, Microneedle Arrays, and Tattoo Devices}, and Without Needle {Intradermal Liquid Jet Devices and Ballistic Intradermal Injectors}), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), and End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)
Joint Pain Injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug (Hyaluronic Acid, Corticosteroid, and Others), Joint Type (Knee, Foot and Ankle, Shoulder and Elbow, Hip, and Others), and Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, and Others)
Needle Free Drug Delivery Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technique (Inhalers, Transdermal Patch, Jet Injectors, Novel Needle Free); Application (Pediatric Injection, Insulin Delivery Devices, Vaccine Delivery Devices, Others) and Geography
Needle Free Diabetes Care Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Device Type ( Treatment Devices, Diagnostics Devices ); End User ( Diagnostic Centers, Hospitals and Clinics, Consumer ) and Geography
Wearable Injectors Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type (On-Body Injectors and Off-Body Injectors), Application (Diabetes, Oncology, Cardiovascular Disease, Autoimmune Disease, and Other Applications), and End User (Hospitals & Clinics, Homecare Setting, and Other End Users)
Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Electronic Wearable Injectors, Mechanical Wearable Injectors, and Infusion Pumps); Application (Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, and Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies), and Geography
Pen Needles Market to 2025 - Global Analysis and Forecasts By Type (Standard and Safety), Therapy (Insulin, GLP-1, and Growth Hormone), Length (4mm, 5mm, 6mm, 8mm,10mm, and 12mm) and Geography
Cardiovascular Needle Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Round-Bodied Needles and Cutting Needles), Application (Open Heart Surgery and Cardiac Valve Procedures), Usage (Single Use and Multiple Uses), and End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Cardiovascular Centers) Geography
Hypodermic Needles Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Safety Needles and Non-Safety Needles), Application (Drug Delivery, Vaccination, and Blood Specimen Collection), End User (Diagnostic Centers, Hospitals and Clinics, and Home Health Care), and Usage (Disposable and Reusable)
Insulin Delivery Devices Market to 2025 - Global Analysis and Forecasts By Product (Insulin Pens, Insulin Pumps, Insulin Syringes, Pen Needles, and Others), End User (Patients/Homecare and Hospitals & Clinics), and Geography
Insulin Pens Market to 2027 - Global Analysis and Forecasts By Product Type (Disposable, Reusable and Smart Insulin Pen Caps); Application (Diabetes Type-1 and Diabetes Type-2); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and e-Commerce) and Geography
Smart Insulin Pen Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Application (Type 1 Diabetes, Type 2 Diabetes); Connectivity Type (USB, Bluetooth); Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, On-line Distribution); and Geography
Insulin Delivery Devices Market to 2025 - Global Analysis and Forecasts By Product (Insulin Pens, Insulin Pumps, Insulin Syringes, Pen Needles, and Others), End User (Patients/Homecare and Hospitals & Clinics), and Geography
About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us: If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi E-mail: sales@theinsightpartners.com Phone: +1-646-491-9876 Press Release: https://www.theinsightpartners.com/pr/needle-free-injection-system-market
Though retirees are only required to take a certain portion of their retirement savings out as distributions each year, a study from JPMorgan Chase shows that there is likely good reason to take out more. A withdrawal approach based solely on … Continue reading → The post 84% of Retirees Are Making This RMD Mistake appeared first on SmartAsset Blog.
During tricky market conditions, it can be helpful to follow professional investors who are focused on the long term.
Congressional Democrats want to slam shut a tax loophole known as the "backdoor" Roth IRA. In one of several proposed changes that target the retirement accounts of wealthy Americans, Democrats on the House Ways and Means Committee want to prohibit people … Continue reading → The post Democrats Want to End This Lucrative Retirement Account Loophole appeared first on SmartAsset Blog.
Expect cost certainty to fly right out the (drafty) window.
The EARN Act is the latest addition to the lineup of proposals legislators have put forth to bolster retirement savings. Senators Ron Wyden, a Democrat from Oregon, and Mike Crapo, a Republican from Idaho, introduced the Enhancing American Retirement Act on Thursday. “Americans deserve dignified retirements after decades of hard work, and our bill is an important step forward,” Wyden said in a statement.
It's time to be extra picky.
Berkshire Hathaway is on pace to collect $6.07 billion in dividend income over the next 12 months. Just five holdings will account for 71% of total payouts.
In an effort to streamline the regulation that governs how retirement accounts can be used, the IRS has proposed a change for 403(b) plans - a type of workplace retirement plan use mostly by public and non-profit employees. Employer-sponsored plans … Continue reading → The post The IRS Is Changing How Your Beneficiaries Receive Your Retirement Funds appeared first on SmartAsset Blog.
Deciding when to time your retirement plan withdrawals matters for determining how long your money will last and what you'll pay in taxes for those distributions. If you have a 401(k) at work, you might follow the Rule of 55 … Continue reading → The post Rule of 55 vs. 72(t): Retirement Plan Withdrawals appeared first on SmartAsset Blog.
Millennials are convinced Social Security will vanish by the time they retire. The reality is less dire—but big changes are looming.
If $1 million was once the consensus target for retirement savings in the U.S., that appears to be changing. A recent Schwab Retirement Plan Services survey found that 401(k) plan participants across the country now believe they must save $1.9 … Continue reading → The post 401(k) Plan Participants Say They Need to Save This Much to Retire appeared first on SmartAsset Blog.
With Teekay leading the pack, these are the 5 biggest oil tanker companies by 12-month trailing revenue.
President Joe Biden's administration issued a checklist of actions needed to reign in Big Tech on Thursday, after a roundtable "listening session" on issues within the technology industry. But administration officials were not "listening" to the companies that are the targets of many of the desired actions.
Shareholders sided with the company, which argued it “does not directly source cotton or raw material.”
Creating reliable streams of retirement income is one of the most important elements of a person's financial plan. A retirement industry giant says it now has a new way for retirees to meet this vital challenge. Fidelity Investments plans to … Continue reading → The post There's a New Way to Convert Your 401(k) into a Pension-like Stream of Income appeared first on SmartAsset Blog.
Tesla is getting into a new part of the battery supply chain in a bid to secure raw materials to expand battery capacity for its electric vehicles.
Retirees should worry less about the broader state of Social Security, and more about when they should claim their benefit
(Bloomberg) -- A federal appeals court saved Citigroup Inc. from an epic blunder that became the talk of Wall Street, rejecting a ruling that Revlon Inc. creditors could keep more than half a billion dollars the bank accidentally sent them. Most Read from BloombergCharles Becomes King as the Face of a Nation ChangesDouble Rainbow Appears Over Buckingham Palace as Crowd Gathers to Mourn QueenQueen Elizabeth’s Doctors Are Concerned for Her HealthQueen Elizabeth II, Britain’s Longest-Reigning Monar
The director’s copyright infringement saga is finally being put to rest.
Water cuts of more than 80% for many rice farmers have triggered an acreage decline steeper than for any other major crop in the state, hurting businesses that depend on the grain.